阅读说明：本技术 用于预防或治疗急性髓性白血病或转移性乳腺癌的药物组合物 (Pharmaceutical composition for preventing or treating acute myelogenous leukemia or metastatic breast cancer ) 是由 金容哲 郑平和 于 2018-10-30 设计创作，主要内容包括：本发明涉及一种用于预防或治疗急性髓性白血病或转移性乳腺癌的药物组合物,其包含靛玉红衍生物作为活性成分。当使用本发明的化合物时,它可有效地抑制FLT3激酶的活性,并可有效地用于预防或治疗急性髓性白血病或转移性乳腺癌。(The present invention relates to a pharmaceutical composition for preventing or treating acute myeloid leukemia or metastatic breast cancer, comprising indirubin derivatives as an active ingredient. When the compound of the present invention is used, it can effectively inhibit the activity of FLT3 kinase and can be effectively used for the prevention or treatment of acute myelogenous leukemia or metastatic breast cancer.)